Ryan Webler, BA

  • 2Articles
  • 15.8KReads1
  • 2017–2018Active
  • 6Collaborators
  • 84Citations2

About

Ryan Webler, BA, has contributed to research published in Psychiatrist.com focusing on neurology and psychiatry, particularly in the areas of seizure disorders and clinical treatment outcomes. Webler's work includes studies on ketamine use in psychiatric settings and case reports involving cannabis-induced psychosis and antipsychotic-related seizures. Collaborations with authors such as Gerard Sanacora and Samuel T. Wilkinson are noted in these publications from 2017 to 2018.

Publications

JCP
Original Research

Ketamine as a Clinical Treatment for Mood Disorders

July 24, 2018

Ketamine, an off-label treatment for depression, can have rapid-acting antidepressant effects but is also sometimes associated with negative clinical outcomes. Do the short- and long-term benefits of ketamine treatment...
, , , et al
PCC
Letter to the Editor

When the Solution Causes a Bigger Problem

February 2, 2017

In this case of cannabis-induced psychosis, the patient experienced worsening psychosis the more he was treated with antipsychotics. And then seizures? Read how the cycle was ended.
,

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe